Drug intelligence / Profile preview

methenamine + sodium phosphate + phenyl salicylate + methylene blue + hyoscyamine

Development stage
Unknown
Lead developer
Method Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

This combination drug is an oral medication indicated for the treatment of symptoms associated with lower urinary tract infections and irritations, such as pain, burning, and frequency. It is also used to relieve discomfort following diagnostic procedures. The formulation contains five active components: methenamine, which acts as a prodrug that converts to the bactericidal agent formaldehyde in acidic urine; sodium phosphate, which serves as a urinary acidifier to facilitate methenamine's conversion; hyoscyamine, an antispasmodic that antagonizes muscarinic acetylcholine receptors to reduce bladder spasms; phenyl salicylate, which provides mild analgesic and antiseptic effects; and methylene blue, a weak antiseptic. This multi-modal approach addresses both the underlying bacterial presence and the symptomatic spasms and pain associated with urinary tract conditions.

Brand names
Uro-MPUretron DSUrogesic BlueUtira-CUrylUro-BlueVilamit MBHyophenPhosphasalUro-LUrophen MBUstell
Other names
methenamine + sodium phosphate monobasic + phenyl salicylate + methylene blue + hyoscyamine sulfate
02

Targets

CHRM3 (M3)CHRM2 (M2)M1 (Muscarinic acetylcholine receptor M1)

Beyond the preview

Go deeper on methenamine + sodium phosphate + phenyl salicylate + methylene blue + hyoscyamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methenamine + sodium phosphate + phenyl salicylate + methylene blue + hyoscyamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call